CANCER OF PANCREAS
Clinical trials for CANCER OF PANCREAS explained in plain language.
Never miss a new study
Get alerted when new CANCER OF PANCREAS trials appear
Sign up with your email to follow new studies for CANCER OF PANCREAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer pill targets KRAS and EGFR mutations in early human trial
Disease control OngoingThis early-stage study is testing a new oral medication called HBI-2376 in people with advanced solid tumors that have specific KRAS or EGFR mutations. The main goals are to find the highest safe dose of the drug and to understand how the body absorbs and processes it. The trial …
Matched conditions: CANCER OF PANCREAS
Phase: PHASE1 • Sponsor: HUYABIO International, LLC. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New hope for tough cancers: first test of experimental KRAS-Targeting pill
Disease control OngoingThis is the first human study of an experimental oral medication called HBI-2438 for people with advanced solid tumors that have a specific genetic change called KRAS G12C. The main goals are to find the highest safe dose and understand how the body processes the drug. The study …
Matched conditions: CANCER OF PANCREAS
Phase: PHASE1 • Sponsor: HUYABIO International, LLC. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New program aims to unite cancer and heart doctors for better patient care
Disease control OngoingThis study tests a new program designed to improve teamwork between cancer specialists and primary care doctors (PCPs) for patients who have both cancer and a heart-related condition like high blood pressure or diabetes. The goal is to see if better coordination helps manage the …
Matched conditions: CANCER OF PANCREAS
Phase: NA • Sponsor: Duke University • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC